Start main content

Synthetic Bacteria Vaccine Against Antibiotics Resistant Bacteria

Synthetic Bacteria Vaccine Against Antibiotics Resistant Bacteria
Field
Vaccine
Patent
IP01080

Key Problem and Market Opportunity

Some pseudaminic acid bacteria, such as Acinetobacter baumanniiPseudomonas aeruginosa were listed as “priority list” by WHO. However there are a lack of effective antibiotics to treat them. 

Key Advantages of the Technology

Technology Section Slider 1
Technology Section Slider 2

The underlying mechanism is a conjugation of pseudaminic acid which exits in pathogens to a carrier protein CRM197 to form anti-bacteria conjugate vaccines.

Benefits

  • Promising protection efficacy 
  • Cost‑effective

Potential Product and Services

Vaccine for Pse carrying bacteria, e.g. Acinetobacter baumanniiPseudomonas aeruginosa, and Campylobacter jejuni.

Development Status and IP Strength

Patents
  • US provision application
IP Status
  • Patent application submitted

Work with us